Alphamab nabs more than $100 mln Series A
China-based Alphamab Oncology, a biopharmaceutical company focused on treating cancer, has raised more than $100 million in Series A funding. The investors included Advantech Capital, PAG,OrbiMed, Heritage Provider Network and Janchor Partners.
16 November 2018•1 min read
